Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01952288 · ClinicalTrials.gov registry record · Phase 4
Simvastatin for mTBI
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT01952288: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT01952288 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01952288, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
Study of simvastatin in Iraq/Afghanistan Veterans with multiple blast exposure and mTBI. The study will measure substances in cerebrospinal fluid (CSF) that are related to dementing disorders.
Interventions
- DRUG Placebo Oral Tablet
- DRUG simvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-09-16 |
| Est. Completion | 2017-06-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01952288
The ClinicalTrials.gov registry entry for NCT01952288 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT01952288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01952288 about?
NCT01952288 is a clinical study titled "Simvastatin for mTBI". Study of simvastatin in Iraq/Afghanistan Veterans with multiple blast exposure and mTBI. The study will measure substances in cerebrospinal fluid (CSF) that are related to dementing disorders.
What is the current status of trial NCT01952288?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2013-09-16. Estimated completion is 2017-06-20.
What interventions are being tested in trial NCT01952288?
The interventions under investigation include: Placebo Oral Tablet (DRUG), simvastatin (DRUG).
Who is sponsoring clinical trial NCT01952288?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.